Login to Your Account



Targets Flow from Genomewide Study of Blood Formation Genes

By Sharon Kingman
BioWorld International Correspondent

Wednesday, December 7, 2011
LONDON – A slew of genes involved in the development of blood cells could become new targets for therapies to treat a whole range of conditions, from inherited blood clotting disorders and anemia to thrombotic events, including myocardial infarction.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription